UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics

Clinical infectious diseases, 2016-01, Vol.62 (1), p.53-59

2016

Link zum Volltext

Verfügbarkeit prüfen

Quantifying lung ultrasound comets with a convolutional neural network: Initial clinical results

Computers in biology and medicine, 2019-04, Vol.107, p.39-46

2019

Link zum Volltext

Verfügbarkeit prüfen

The Use of Modeling to Compare Tuberculosis Dynamics in Four U.S. States

American journal of respiratory and critical care medicine, 2017-10, Vol.196 (8), p.953-954

Burzynski, Joseph

2017

Link zum Volltext

Verfügbarkeit prüfen

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do

American journal of respiratory and critical care medicine, 2020-12, Vol.202 (11), p.1499-1500

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in the Transmission of Tuberculosis in New York City from 1990 to 1999

The New England journal of medicine, 2002-05, Vol.346 (19), p.1453-1458

2002

Link zum Volltext

Verfügbarkeit prüfen

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

PLOS global public health, 2023, Vol.3 (4), p.e0001758-e0001758

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of an Interferon-γ Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients

Chest, 2008-04, Vol.133 (4), p.869-874

2008

Link zum Volltext

Verfügbarkeit prüfen

Use of Modeling to Inform Tuberculosis Elimination Strategies

American journal of respiratory and critical care medicine, 2020-02, Vol.201 (3), p.272-274

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of Therapeutic Drug Monitoring for Multidrug-Resistant Tuberculosis Patients

Chest, 2004-12, Vol.126 (6), p.1770-1776

2004

Link zum Volltext

Verfügbarkeit prüfen

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

The New England journal of medicine, 2021-05, Vol.384 (18), p.1705-1718

2021

Link zum Volltext

Verfügbarkeit prüfen

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

The New England journal of medicine, 2011-12, Vol.365 (23), p.2155-2166

2011

Link zum Volltext

Verfügbarkeit prüfen

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

Journal of medical Internet research, 2018-11, Vol.20 (11), p.e287-e287

2018

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in Testing for Latent TB

Chest, 2010-12, Vol.138 (6), p.1456-1463

2010

Link zum Volltext

Verfügbarkeit prüfen

Process monitoring of polysaccharide deketalization for vaccine bioconjugation development using in situ analytical methodology

Journal of pharmaceutical and biomedical analysis, 2022-02, Vol.209, p.114533-114533, Article 114533

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid

JAMA pediatrics, 2015-03, Vol.169 (3), p.247

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018)

American journal of public health (1971), 2020-11, Vol.110 (11), p.1696-1703

2020

Link zum Volltext

Verfügbarkeit prüfen

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

American journal of respiratory and critical care medicine, 2009-08, Vol.180 (3), p.273-280

2009

Link zum Volltext

Verfügbarkeit prüfen

Rifampin Mono-Resistant Tuberculosis in New York City, 2010–2021: A Retrospective Case Series

Open forum infectious diseases, 2023-11, Vol.10 (11), p.ofad534-ofad534

2023

Link zum Volltext

Verfügbarkeit prüfen

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Clinical infectious diseases, 2023-10, Vol.77 (7), p.1053-1062

2023

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis Control in New York City — A Changing Landscape

The New England journal of medicine, 2014-06, Vol.370 (25), p.2362-2365

2014

Link zum Volltext

Verfügbarkeit prüfen

Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium

The Journal of infectious diseases, 2012-10, Vol.206 (7), p.1030-1040

2012

Link zum Volltext

Verfügbarkeit prüfen

NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings

Clinical infectious diseases, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

PLOS global public health, 2023-01, Vol.3 (4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of Pediatric Multidrug-Resistant Tuberculosis and Latent Tuberculosis Infections in New York City From 1995 to 2003

The Pediatric infectious disease journal, 2008-10, Vol.27 (10), p.907-912

2008

Link zum Volltext

Verfügbarkeit prüfen

Infectious Disease Hospitalizations, New York City, 2001-2014

Public health reports (1974), 2020-09, Vol.135 (5), p.587-598

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(26)
Tuberculosis
(24)
General & Internal Medicine
(15)
Female
(14)
Male
(14)
Adult
(12)
Antitubercular Agents - Therapeutic Use
(11)
Infectious Diseases
(10)
Middle Aged
(9)
Biological And Medical Sciences
(8)
Critical Care Medicine
(8)
Medical Sciences
(8)
Respiratory System
(8)
Medicine, General & Internal
(7)
Public Health
(7)
Risk Factors
(7)
Tuberculosis - Drug Therapy
(7)
United States
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics

Quantifying lung ultrasound comets with a convolutional neural network: Initial clinical results

The Use of Modeling to Compare Tuberculosis Dynamics in Four U.S. States

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do

Changes in the Transmission of Tuberculosis in New York City from 1990 to 1999

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

Use of an Interferon-γ Release Assay To Diagnose Latent Tuberculosis Infection in Foreign-Born Patients

Use of Modeling to Inform Tuberculosis Elimination Strategies

Use of Therapeutic Drug Monitoring for Multidrug-Resistant Tuberculosis Patients

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

Recent Advances in Testing for Latent TB

Process monitoring of polysaccharide deketalization for vaccine bioconjugation development using in situ analytical methodology

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid

Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018)

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

Rifampin Mono-Resistant Tuberculosis in New York City, 2010–2021: A Retrospective Case Series

Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease

Tuberculosis Control in New York City — A Changing Landscape

Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium

NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings

Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022

Management of Pediatric Multidrug-Resistant Tuberculosis and Latent Tuberculosis Infections in New York City From 1995 to 2003

Infectious Disease Hospitalizations, New York City, 2001-2014

Suchergebnisse filtern